NCCP (n = 279) (%) | Controls (n = 530) (%) | p-value | |
---|---|---|---|
ACE inhibitors | 8.6 | 5.7 | 0.111 |
AII inhibitors | 6.8 | 4.3 | 0.132 |
β-Blockers | 27 | 16 | <0.001 |
Ca2+-Blockers | 8.6 | 6.6 | 0.299 |
Furosemide | 6.5 | 6.0 | 0.816 |
Thiazides | 15 | 8.5 | 0.004 |
Aspirin | 18 | 11 | 0.013 |
Long-acting nitrates | 4.7 | 1.1 | 0.002 |
Statins | 13 | 9.2 | 0.078 |
Agents for acid-related disordersa | 13 | 2.8 | <0.001 |
Analgesics and NSAID | 7.9 | 5.5 | 0.179 |
Anti-diabetic medication | 4.7 | 4.2 | 0.735 |
COPD agents | 7.5 | 3.6 | 0.014 |
Anti-depressants | 7.9 | 6.0 | 0.317 |
Hypnotics and sedatives | 10 | 8.1 | 0.358 |